Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogeneic Mesenchymal Stem Cell Injection for Knee Osteoarthritis
2023-506088-33-01Phase 2Authorised
- Sponsor
- Aarhus University
- Start
- Feb 2024
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised trial of allogeneic adipose tissue-derived mesenchymal stem cells in knee osteoarthritis (OA) (2 arms), sponsored by Aarhus University. Primary endpoints: Knee symptoms (KOOS) and Pain diary and adverse events. Planned start Feb 2024; status: authorised.
02
Drugs
allogeneic adipose tissue-derived mesenchymal stem cells
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2023-506088-33-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-506088-33-01.